Grippol® Quadrivalent: Four Strains Protection
A modern Russian subunit adjuvanted influenza vaccine, Grippol® Quadrivalent,
was registered in 2018. Unlike previous vaccines, it contains 4 strains of influenza virus: two are type A (H1N1 and H3N2) and
two are type B in the Yamagata and Victoria strains.
The addition of a second B strain has extended protection against influenza infection — group B viruses also circulate frequently in the
Northern Hemisphere and cause incidence and severe infection course.
The Polyoxidonium adjuvant at a rate of 500 µg per vaccine dose reduced antigen content and reduced the likelihood of developing reactions in response to vaccination.
This vaccine contains no preservatives or antibiotics and, like Grippol® Plus, is produced in a GMP-compliant facility: any foreign particles or germs are excluded.
Grippol® Quadrivalent is used to vaccinate people aged 6 to 60 years and is highly effective and safe.